Latest Technology News

Cettire returned to positive operating cash flow in FY26, but its annual report carries a material uncertainty over going concern after current liabilities exceeded current assets by A$51.8 million. The luxury e-commerce group also posted an A$8.5 million statutory loss and is relying on working-capital discipline, VAT recoveries and potentially conditional director support.

Ocean Sciences delivered a sharp increase in seaweed revenue during FY2026, but the audited report also records a A$1.612 million continuing-operations loss, A$2.319 million operating cash outflow and material uncertainty over its ability to continue as a going concern. The renamed ASX-listed group is now seeking up to A$3 million while building out its Indonesian platform.

Battery Age Minerals finished FY26 with stronger cash reserves and drilling progress across Austria and Argentina, but warned that further funding or asset realisations are needed to sustain planned exploration. The company reported a $4.97 million loss, including a $2.60 million non-cash charge linked to its diluted Eminence Minerals holding.

Iltani Resources has paired a substantial Orient silver-indium resource with $8 million in QIC backing, giving the explorer a stronger platform for its next phase of drilling and technical studies. The company remains loss-making and pre-revenue, but ended FY26 with $7.5 million in cash.

Green Technology Metals has cleared the environmental assessment for its Seymour lithium project, while a A$15.9 million capital raising leaves the company better placed to complete its definitive feasibility study. The next test is whether permitting, financing and Indigenous agreements can convert that progress into a Final Investment Decision in FY27.

PTR Minerals has posted a 463 million tonne maiden resource for its Rosewood titanium project, backed by strong early processing results and fresh funding. The next test is whether the large geological inventory can become an economically viable mine.

AdNeo Limited (ASX: AD1) nearly doubled operating revenue in FY26 and delivered its first full-year operating cash inflow, marking a sharp turnaround after the Learnt Global acquisition. The recovery remains incomplete, with a $3.97 million loss, significant current liabilities and an auditor-drawn material uncertainty over going concern.

ACDC Metals enters FY27 with a larger Nevada exploration footprint and a 10-year licence over its Goschen Central rare earths project, but a sharply higher annual loss and ongoing funding needs remain part of the picture. The company plans up to 2,500 metres of reverse-circulation drilling at Mount Jackson in Q4 CY2026.

TrivarX has made Stabl-Im its central development bet, but the ASX-listed health technology company also reported an $8.76 million FY2026 loss and an auditor-flagged material uncertainty over its ability to continue without further funding. The planned Phase 1 study remains subject to regulatory, ethics and operational clearances.

Rhythm Biosciences has moved ColoSTAT and geneType into commercial use, recording its first sales during FY2026. But with sales revenue of just $85,339, a $5.93 million loss and an auditor-flagged going-concern uncertainty, the next phase will be judged on cash generation and repeat adoption.

ASF Group strengthened its balance sheet in FY2026 by selling non-core investments and subsidiaries, lifting cash to A$5.19 million and eliminating borrowings. Profit attributable to shareholders fell sharply as the prior year benefited from a one-off gain, leaving the investment group reliant on future portfolio realisations and development projects.

AnteoTech has received $1.905 million from the Australian R&D Tax Incentive, providing fresh cash for its battery materials and life sciences commercialisation efforts. The rebate relates to eligible research conducted during the 2026 financial year.